BIOLASE® to Host 2017 First Quarter Financial Results Conference Call on May 3

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, May 3, 2017, at 4:30 p.m. Eastern Time to discuss its operating results for its first quarter ended March 31, 2017, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.

Phone ParticipationTo listen to the conference call live via telephone, dial 1-877-407-4019 from the U.S. or, for international callers, dial 1-201-689-8337, approximately 10 minutes before the start time.

Webcast ParticipationTo listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at www.biolase.com.

ReplayAn audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x-rays and CAD/CAM intra-oral scanners. BIOLASE’s products advance the practice of dentistry and medicine for patients and health care professionals. BIOLASE's proprietary laser products incorporate approximately 230 patented and 85 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE’s innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 33,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase® iPlus™, Waterlase® express™, Epic pro™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and Waterlase® are registered trademarks of BIOLASE, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170426005217/en/

DresnerAllenCaron
Rene Caron (Investors)
949-474-4300
[email protected]
or
Len Hall (Media)
949-474-4300
[email protected]

Source: BIOLASE, Inc.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Hilltop Holdings (HTH) Tops Q1 EPS by 17c
• Southern First Bancshares, Inc. (SFST) Misses Q1 EPS by 8c